| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/15/1998 | WO1998001560A1 Modified protein g and fragments thereof |
| 01/15/1998 | WO1998001559A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/15/1998 | WO1998001558A2 Protein and peptide vaccines for inducing mucosal immunity |
| 01/15/1998 | WO1998001557A2 Mammalian chemokine reagents |
| 01/15/1998 | WO1998001556A1 A lysosomal-associated multispanning membrane protein, laptm5 and a nucleic acid encoding laptm5 |
| 01/15/1998 | WO1998001555A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001553A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001552A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001551A1 Tyrosine kinase associated protein-1 (tka-1), nucleotide and amino acid sequences and their use in diagnosis and treatment of tka-1 related disorders |
| 01/15/1998 | WO1998001550A2 Vaccine against gastro-intestinal nematodes |
| 01/15/1998 | WO1998001549A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | WO1998001548A1 Oligomerized receptors which affect pathways regulated by transmembrane ligands for elk-related receptor tyrosine kinases |
| 01/15/1998 | WO1998001547A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 01/15/1998 | WO1998001546A2 Polyketides and their synthesis |
| 01/15/1998 | WO1998001541A1 Traf2-associated protein kinase and assays |
| 01/15/1998 | WO1998001540A1 Method for producing therapeutic dna |
| 01/15/1998 | WO1998001538A1 Method of activating dendritic cells |
| 01/15/1998 | WO1998001535A1 Method for the production of polypeptides |
| 01/15/1998 | WO1998001534A1 Novel methods and compositions for combinatorial-based discovery of new multimeric molecules |
| 01/15/1998 | WO1998001533A1 Cleavable signal element device and method |
| 01/15/1998 | WO1998001473A1 Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides |
| 01/15/1998 | WO1998001470A1 A transcription factor |
| 01/15/1998 | WO1998001467A2 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | WO1998001465A1 Neuroactive peptide |
| 01/15/1998 | WO1998001460A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | WO1998001221A1 Electrochemical solid phase synthesis of polymers |
| 01/15/1998 | WO1998001162A2 Gene delivery system |
| 01/15/1998 | WO1998001161A2 Gene therapy delivery system for targeting to endothelia |
| 01/15/1998 | WO1998001160A2 Compositions suitable for delivery of genes to epithelial cells |
| 01/15/1998 | WO1998001154A2 Treatment and diagnosis of infections of gram positive cocci |
| 01/15/1998 | WO1998001153A1 Medicinal compositions for extracorporeal blood circulation circuit and method for inhibiting blood coagulation in extracorporeal blood circulation circuit |
| 01/15/1998 | WO1998001149A2 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE |
| 01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/15/1998 | WO1998001027A1 In vivo electroporation method for early animal embryo |
| 01/15/1998 | WO1997046673A3 Inhibition of hiv-1 replication by antisense rna expression |
| 01/15/1998 | WO1997045547A3 Localised cell death in plants |
| 01/15/1998 | WO1997040166A3 Simian-human hav having a chimeric 2c protein |
| 01/15/1998 | WO1997035983A3 Cysteine protease promoter from oil seed rape and a method for the containment of plant germplasm |
| 01/15/1998 | WO1997034926A3 Bacillus thuringiensis genes encoding nematode-active toxins |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | CA2741501A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 01/15/1998 | CA2263098A1 A lysosomal-associated multispanning membrane protein, laptm5 and a nucleic acid encoding laptm5 |
| 01/15/1998 | CA2260368A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/15/1998 | CA2260361A1 Cleavable signal element device and method |
| 01/15/1998 | CA2260360A1 Use of a panel of heterokaryons to produce variants of multimeric proteins |
| 01/15/1998 | CA2260295A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2260293A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2260274A1 Heat-stable dna polymerase of archaeobacteria of genus pyrococcus sp. |
| 01/15/1998 | CA2259983A1 Transformation of zygote, egg or sperm cells, and regeneration of transformed plants from isolated embryo sacs |
| 01/15/1998 | CA2259965A1 Hiv envelope polypeptides and vaccine |
| 01/15/1998 | CA2259961A1 Protein and peptide vaccines for inducing mucosal immunity |
| 01/15/1998 | CA2259957A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259942A1 Process for producing icosapentaenoic acid by genetic recombination |
| 01/15/1998 | CA2259908A1 In vivo electroporation method for early animal embryo |
| 01/15/1998 | CA2259628A1 Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process |
| 01/15/1998 | CA2259618A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | CA2259463A1 Polyketides and their synthesis |
| 01/15/1998 | CA2259158A1 Transformation-associated recombination cloning |
| 01/15/1998 | CA2259157A1 Oligomerized receptors which affect pathways regulated by transmembrane ligands for elk-related receptor tyrosine kinases |
| 01/15/1998 | CA2259154A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | CA2259149A1 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | CA2259137A1 Neuroactive peptide |
| 01/15/1998 | CA2258792A1 Method for producing therapeutic dna |
| 01/15/1998 | CA2257408A1 Compositions suitable for delivery of genes to epithelial cells |
| 01/15/1998 | CA2257300A1 Gene therapy delivery system for targeting to endothelia |
| 01/15/1998 | CA2231427A1 A novel human ubiquitin-conjugating enzyme technical field |
| 01/15/1998 | CA2210520A1 Homologous recombination for animal model exhibiting reduced levels or elimination of a neuronal intermediate filament |
| 01/14/1998 | EP0818541A1 Species-specific detection of mycobacterium kansasii |
| 01/14/1998 | EP0818538A1 Novel cellulases |
| 01/14/1998 | EP0818537A2 Method for cloning and producing the SapI restriction endonuclease in E. coli |
| 01/14/1998 | EP0818536A1 Dna molecule relating to suppression of gene expression and novel protein |
| 01/14/1998 | EP0818535A1 Novel yeast genes |
| 01/14/1998 | EP0818534A1 Human Interleukin 12 gene expression regulating sequences |
| 01/14/1998 | EP0818533A2 Novel isoform gene for focal adhesion protein paxillin |
| 01/14/1998 | EP0818532A1 Plant promoter and gene expression with the use of the same |
| 01/14/1998 | EP0818466A2 Purified, biologically active bacterially produced recombinant human CSF-1 |
| 01/14/1998 | EP0818461A2 Method for isolating ribonucleic acid |
| 01/14/1998 | EP0818138A1 Method for creating osmotic-pressure-tolerant plant |
| 01/14/1998 | EP0817967A1 Insulin mimetic and enhancer assay |
| 01/14/1998 | EP0817861A1 Gene transfer into the kidney |
| 01/14/1998 | EP0817860A1 Pseudotyped retroviral particles |
| 01/14/1998 | EP0817859A1 Novel recombinant dna vectors for gene therapy |
| 01/14/1998 | EP0817858A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 01/14/1998 | EP0817857A1 Control of pod dehiscence |
| 01/14/1998 | EP0817856A1 Introduction of dna into bacillus strains by conjugation |
| 01/14/1998 | EP0817855A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors |
| 01/14/1998 | EP0817854A2 Antigen presentation system based on retrovirus-like particles |
| 01/14/1998 | EP0817853A1 Infectious dna clone of the tick-borne encephalitis (tbe) virus; recombinant vaccine derived from the said clone and production of the said vaccine; and a pharmaceutical product containing a replicable nucleic acid |
| 01/14/1998 | EP0817852A2 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
| 01/14/1998 | EP0817851A2 Dna encoding human papilloma virus type 18 |
| 01/14/1998 | EP0817850A1 Plant pathogen resistance genes and uses thereof |
| 01/14/1998 | EP0817849A1 Genetic sequences conferring nematode resistance in plants and uses therefor |
| 01/14/1998 | EP0817848A1 In vivo generation of antibodies against antigens secreted in a host by transfected mel cells |
| 01/14/1998 | EP0817847A1 Il-17 receptor |
| 01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 01/14/1998 | EP0817845A1 Conditional expression system |
| 01/14/1998 | EP0817844A1 T-cell receptors and their use in therapeutic and diagnostic methods |
| 01/14/1998 | EP0817843A2 Vectors for differential expression |